Company Overview
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
Key Highlights
- Biotechnology · Healthcare
- Led by Sandeep C. Kulkarni
- 40 employees
- Based in Henderson, NV
Price History
Loading…
Data from Twelve Data. Prices may be delayed.
Analyst Coverage
View All Coverage →No analyst coverage available.
Economic Calendar
View more →- Nov 12
Initial Jobless Claims
8:30 AM ET
Crypto Prices
View more →
Bitcoin (BTC)
75,326 +0.88%
Ethereum (ETH)
2,133 +0.15%
Solana (SOL)
87 −0.08%
Company Facts
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Henderson, NV, US
- Incorporated
- Mar 21, 2023
- Website
- zurabio.com
Latest SEC Filings
View All Filings →- Current Report (Form 8-K)Nov 9, 2026